SlideShare ist ein Scribd-Unternehmen logo
1 von 58
PRESENTED BY—DR. ANINDYA DAS
PGT, . DEPT. OF MICROBIOLOGY
GMCH
 Bacterial metabolism is a dynamic balance
between anabolic reactions and catabolic
reactions.
 Catabolic reactions, in addition to providing
smaller building blocks for subsequent
biosynthetic processes also provide energy in
the form of ATP.
 Using this energy, bacterial cell wall,proteins
nuclic acids,other structural and regulatory
macromolecules are synthesised.
 Bacteria that derive their energy from organic
compounds are called chemoorganotrphs.
 Most of the bacteria encountered in clinical
medicine derive energy from the utilization of
carbohydrates by one of several metabolic
pathways.
 Some free-living bacteria, such as the nitrogen-
fixing groups or those capable of oxidizing sulfur
or iron can derive energy from inorganic
chemicals.They are called Chemolithotrophs.
 Some bacteria, such as Moraxella, do not
metabolize carbohydrates, but derive energy
from degradation of other compounds,like amino
acids, alcohols and organic acids.
 Utilization of carbohydrates by bacteria and the
condition under which this utilization occurs are
key characteristics for broadly characterizing
bacteria.
 Many tests performed in Microbiology lab. for
identification of bacteria are actually detection
of the end products of bacterial metabolism.
 Bacterial degradation of carbohydrate proceeds
by three major pathways: Embden-Meyerhof-
Parnas, Entner-Doudoroff and HMP pathway.
 Glucose is converted to pyruvic acid in each of
these three pathway by a different set of
degradation steps.
 Bacteria use one or more of these pathways for
glucose metabolism depending on their
enzymatic composition and the presence or lack
of oxygen.
 Utilization of glucose under anaerobic
condition is termed fermentation.It occurs
via glycolysis or EMP pathway with the
intermediate product being pyruvic acid.
 Pyruvate is then oxidized by giving up its H+
ion to Na-lactate to form lactic acid or to
other organic salts to form mixed acids.
 These acids are the end products of
fermentation process accounting for the drop
in Ph.
 Bacteria that possess appropriate enzyme
system can further degrade mixed acids into
alcohols,carbon-di-oxide,or other compound.
 Due to the absence of dehydrogenase
enzyme some bacteria cannot ferment
glucose.
 They oxidatively metabolise glucose through
Entner-Doudoroff pathway by forming 6-
phosphogluconate before forming pyruvate
and then transfer H+ into Krebs cycle.They
are called Non-fermenters.
 The acids produced in ED pathway and Kreb’
cycle are extremely weak compared with the
mixed acids produced in fermentation.
 As the end product of oxidative metabolism
is water, no gas formation occurs here.
 So the nonfermentative gram-negative bacilli
are a group of aerobic,non-sporeforming
bacilli that either do not use carbohydrate as
a source of energy(eg. Moraxella) or degrade
them through pathways other than
fermentation.
In Microbiology lab.
nonfermenters are
used to mean all
aerobic gram-
negative rods that
show abundant
growth within 24hrs
on the surface of KIA
or TSI media, but
neither grow in nor
acidify the butt of
media
 Achromobacter
 Acidovorax
 Acinetobacter
 Agrobacterium
 Alcaligenes
 Bordetella
 Brevundimonas
 Burkholderia
 Stenotrophomonas
 Chryseobacterium
 Chryseomonas
 Comamonas
 Flavimonas
 Flavobacterium
 Methylobacterium
 Moraxella
 Weeksella
 Ochrobactrum
 Oligella
 Pseudomonas
 Psychrobacter
 Roseomonas
 Shewanella
 Sphingobacterium
 Delftia
 Ralstonia
 They are predominantly opportunistic.
 Pathogenecity of the organism is usually
related to an altered or already debilitated
host.
 Nomenclature of these organisms changes
rapidly due to defining of new genera with
the use of molecular techniques.
 They will grow on routine isolation media
like blood agar, chocolate agar plate.
 Growth on MacConkey agar is variable and
this property is used for identification.
 Optimum temperature of incubation ranges
from 22-35ºC.
 Most of them require an incubation time of
at least 24 hrs, sometimes 48-72 hrs.
 Most nonfermenters are oxidase +ve, but
enterobacteriaceae are oxidase −ve.
 Not all nonfermenters grow on MacConkey
agar. Nonfermenters that grow on MacConkey
agar are lactose negative.
 Acid produced by nonfermenters are so weak
that normal culture broths designed to
detect acid produced by fermenters are not
suitable for them.It can be easily identified
in Hugh-Leifson OF media.
 Some nonfermenters that are unable to
utilize carbohydrates as energy sources are
termed nonsaccharolytic or asaccholytic, eg-
Moraxella, Alcaligenes etc.
 Nonfermenters can rapidly develop
resistance to antimicrobial agents used in
treating infection.
 A number of pigments are produced by
nonfermenters, which are helpful in species
identification,eg- carotenoids, violacein,
phenazines, fluorescein, pyocyanine etc.
 Organisms characterized as nonfermentative
GNB are first differentiated based upon the
combination of following three reactions-
1) Glucose oxidizer or glucose
inactive(asaccharolytic).
2) MacConkey agar growth present or absent.
3) Oxidase+ve or oxidase−ve.
 Once placed on one of the above groupings,
the organisms are identified using a specific
set of differential media(can be conventional
or commercial systems like API 20NE, Vitek 1
and 2 system, Phoenix-Becton Dickinson etc.)
or by species-specific rRNA based PCR assays.
 Speciation of these organisms can be
difficult.Reliability of commercial systems
with some of these organisms is variable.
 Pseudomonas is the most commonly isolated
nonfermenting GNB.
 Distribution is world wide and associated
with water and moist environment.
 Obligate aerobe,slender GNB,1.5-3x0.5µm.
 Motile by polar monotrichus or multitrichus
(tufts of) flagella.
 Cytochrome oxidase positive.
 Utilize carbohydrates oxidatively.
 Grow on MacConkey agar producing non-lactose
fermenting colonies.
 Most commonly isolated species in the genus is
Pseudomonas aeruginosa.
 One of the leading causes of hospital acquired
infection.
 Not usually part of normal flora of healthy
individuals.
 Colonization occurs in the GI tract, throat,
nasal mucosa, axilla and perinium.
 Produces pigments like pyocianin(blue green)
pyoverdin(yellow-green or yellow-brown,
fluorescent), pyorubin(red), pyomelanin.
 Cetrimide agar can be used to detect
pyocyanin and pyoverdin production and
selectively isolate the organism.
 Colony morphology: BAP- spreading, flat,
irregular edge, gray-green, with a metallic
sheen, possibly mucoid, beta-hemolytic, and a
grape like or corn taco-like odor.
 MAC-clear, nonlactose fermenting colony.
 Gram Stain morphology:thin gram −ve rod.
 Pigment production: Pyocyanin, Pyoverdin,
Pyomelanin, Pyorubin.
 Glucose utilisation: glucose oxidizer(TSI-
K/K, no gas, no H2S.)
 Oxidase: Positive
 Catalase:Positive
 Lactose: Negative
 Mannitol: Negative
 Sucrose: Negative
 42ºC growth: Positive
 Arginine dihydrolase: Positive
 Lysine decarboxylase: Negative
 Ornithine decarboxylase: Negative
 Gelatine hydrolysis: Variable
 Nitrate: Positive
 Citrate: Positive
 Urease: Variable
 Acetamide: Positive
 Polymyxin-B: Sensitive
 VIRULENCE FACTORS:
 Pilli(attach to cell surface)
 Lipopolysaccharide(endotoxin)
 Alginate(capsular polysaccharide inhibit
phagocytosis and form biofilms)
 Exotoxin A: inhibit protein synthesis.
 Other extracellular enzymes and toxins like
proteases, elastase, neuraminidase,
phospholypase-C, leucocidin, enterotoxin.
 Pyocyanin: suppress other bacteria, disrupt
respiraory cilliary activity.
 Type of patients infected by Pseudomonas:
 Leukocytopenic pt.
 Immunosuppressed pt.
 Extensive burn pt.
 Cystic fibrosis and Diabetic pt.
 Presence of indwelling foreign devices.
 IV drug abuser.
 Antibiotic therapy.
 Immature immunologic system
 Infected burn wounds.
 Nosocomial infections like pneumonia.
 Chronic pulmonary disease in Cystic fibrosis.
 Septicemia.
 Swimmer’s ear or otitis externa.
 Folliculitis(swimming pool associated)
 Corneal ulcer/keratitis,
 Urinary tract infection,
 Osteomylitis,
 Ecthyma gangrenosum.
 Pseudomonas aeruginosa is resistant to many
commonly used antibiotics like Penicillin,
Ampicillin, many 1st and 2nd generation
Cephalosporins.
 Sensitive to aminoglycosides,some 3rd
generation cephalosporins, antipseudomonal
penicillins(piperacillin,ticarcillin) and
quinolonnes, carbapenems like imipenem,
meropenem and aztreonam.
 Aminoglycosides: affected by conc. of Ca, Mg
ion of the medium.
 The organisms are found in soil, water and
hospital environment and on plants and
foodstuffs.
 Not part of normal human flora but can
cause nosocomial infection.
 LABORATORY IDENTIFICATION:
 Colony morphology:BAP-smooth fairly large
colonies, may have a pale yellow pigment.
 MAC-growth (ambient air)
 Gram morphology:thin GNB, sometimes with
swollen ends, may be filamentous.
 Motility: Negative.
 Oxidase: Positive.
 Glucose: Oxidizer.
 Indole: Positive(may be weak,use Ehrlich’
method).
 Nitrate reduction:Negative.
 Esculine: Positive.
 ONPG: Positive.
 Polymyxin: Resistant.
 Neonatal meningitis and sepsis. Highly
pathogenic for premature infants. High
mortality rate and chance of nursery
epidemic.
 Bacterimia associated with implanted
catheters.
 Other opportunistic infections.
 MIC determination is recommended for
clinically significant isolates.
 Disc diffusion test is unreliable.
 Susceptible to penicillin(usually), vancomycin
(which is unusual for a gram negative
organism), co-trimoxazole, fluoroquinolones,
piperacillin/tazobactum.
 Natural distribution is in water sources,
detergents, disinfectants.Clusters of 9
closely related genomic species.
 Isolated from pts. of CF and CGD.
 LAB. IDENTIFICATION:
 Colony morphology in BAP: smooth, slightly
raised, may be mucoid, non-pigmented,
strong earthy odor.
 MAC: punctate and tenacious, may become
dark pink red after 4-7 days.
 Selective media for isolation is OFPBL media
containing polymyxin B,bacitracin and
lactose. Form yellow colony.
 PC agar: polymyxin B, crystal violate,
ticarcillin. Form pink colony due to lactose
utilization.
 Gram negative rod.
 Oxidase: Positive.
 Growth at 42ºC: Variable.
 Glucose: Oxidizer.
 Arginine dihydrolase: Negative.
 Lysine decarboxylase: Positive.
 Ornithine decarboxylase: Variable.
 Polymyxin B: Resistant.
 CLINICAL SIGNIFICANCE:
 Organisms can be isolated from anesthetics,
nebulizer solutions, IV fiuids and disinfectant
like povidone-iodine, quaternary ammonium
compounds and chlorhexidine.
 Opportunistic pathogen primarily related to
nosocomial infections and cystic fibrosis.
 ANTIBIOTIC THERAPY:
 Resistant to aminoglycosides.
 Sensitive to co-trimoxazole(drug of choice).
 CLSI: if susceptibility done with disc diffusion
only report ceftazidime, meropenem,
minocycline and co-trimoxazole.
 3rd most commonly found nonfermenter in
clinical specimen.
 Ubiquitous in nature.Can be recovered from any
clinical site.
 Important nosocomial pathogen.
 Not considered part of normal human flora. Can
quickly colonize respiratory tract of hospitalized
pts.
 Have considerable genetic diversity.
 BAP: colonies are pale yellow to lavender
green(good growth at 24 hrs).
 Gram negative rods.
 Oxidase: Negative
 Glucose: Oxidizer(weak).
 Growth at 42ºC: Negative.
 Maltose: Strong oxidizer.
 Arginine dihydrolase: Negative.
 Lysine decarboxylase: Positive.
 Ornithine decarboxylase: Negative.
 DNase: Positive.
 Polymyxin B: Sensitive.
 CLINICAL SIGNIFICANCE:
 Usually cause pneumonia, wound infection,
urinary tract infection, bacterimia in
compromised host.
 ANTIBIOTIC THERAPY:
 Inherently resistant to commonly used anti-
pseudomonal drugs.
 Inherently susceptible to co-trimoxazole.
 CLSI recommends broth dilution. Common
antimicrobials include ticarcillin-clavulanate,
levofloxacin and tetracycline.
 If disc diffusion performed, only report
minocycline, levofloxacin and co-
trimoxazole.
 After the genus Pseudomonas,it is the most
frequently isolated nonfermenter.
 Ubiquitous in soil, water and sewage.Can be
part of normal skin flora.
 Organism can survive on moist and dry
surface. Strict aerobe.
 In hospital environment isolated from
ventilators, humidifiers and catheters.
 Colony morphology on BAP is translucent to
opaque, non-pigmented, convex.
 On MAC colonies are colorless to slightly pink
 Gram stain morphology is plump gram −ve
coccobacilli, often appear to be diplococci,
can be confused with Neiserria sp.
 Oxidase: Negative.
 Motility: Nonmotile.
 Nitrate reduction: Negative.
 Glucose: Oxidizer or asaccharolytic.
 A.baumannii is saccharolytic glucose oxidizer.
 Definitive identification: rapid production of
acid from lactose.
 A.lwoffi, A.johnsonii, A.radioresistens are
asaccharolytic.
 Penicillin: Resistant.
 CLINICAL SIGNIFICANCE:
 Generally considered non-pathogenic in
healthy individuals.
 Associated with opportunistic/nosocomial
infection of respiratory tract, urinary tract,
wound and blood.
 ANTIBIOTIC SUSCEPTIBILITY:
 Resistant to a variety of antibiotic like
penicillin, ampicillin, cephalothin; variable
susceptibility to 2nd and 3rd generation
cephalosporin.
 Combined rx with aminoglycoside+ticarcillin
or piperacillin;
sulbactum+cefoperazone;colistin for MDR sp.
 Occur in water, soil, moist area of hospital,
respirators, hemodialysis system, iv soln.
 May be found on skin and in GI tract.
 LAB. DIAGNOSIS:
 Colony morphology of Alcaligenes fecalis is
flat, thin, spreading and rough with an
irregular edge, may have a fruity odor.
 Gram −ve coccobacilli.
 Oxidase: Positive.
 Grow on MacConkey agar.
 Glucose: weak oxidizer or asaccharolytic.
 Motile by peritrichous flagella.
 Reduce Nitrite(not Nitrate).
 Achromobacter xylosoxidans is saccharolytic,
 Glucose: weak oxidizer.
 Xylose: strong oxidizer.
 CLINICAL SIGNIFICANCE:
 Alcaligenes fecalis is opportunistic pathogen
 Isolated from blood, sputum, urine.
 Achromobacter xylosoxidans causes
nosocomial septicemia and pulmonary
complications in Cystic Fibrosis pts. and
intubated children.
 ANTIBIOTIC THERAPY:
 Susceptibility pattern varies.
 Normal flora of skin and mucous membrane.
 Non motile gram negative plump coccobacilli
or diplobacilli.May resist decolorization.
 On BAP tiny pinpoint colonies at 24 hrs., may
pit the agar.
 Most common sp. Moraxella catarrhalis is
very similar to Neisseria sp.
 Oxidase: Positive.
 Catalase: Positive.
 Glucose: non oxidizer(asaccharolytic)
 Indole: negative.
 Penicillin: highly susceptible.
 CLINICAL SIGNIFICANCE:
 Causes nosocomial and opportunistic
infection like respiratory tract infection and
conjunctivitis.
 Production of β-lactamases has been
reported mainly in M.catarrhalis.
 Apart from these organisms some other
medically important nonfermenters, though
they are very rarely isolated from clinical
specimens are Burkholderia mallei and
pseudomallei.
 B.mallei is an obligate parasite of animals
like horses, mules and donkeys causing a RTI
glanders.
 In rare instances,it can be transmitted to
humans through an abrasion of the skin.
 It is gram-negative coccobacillus,only
nonmotile sp. in the genus, oxidase −ve.
 B.pseudomallei causes melioidosis, a glander
like disease in animals and humans.
 The organism has a specific ecological niche,
existing in soil and stagnated water in parts
of south-east asia like-
Thailand,Vietnam,China,Taiwan and part of
north Australia.
 Infection is acquired by direct contact
through break in the skin or by inhalation of
contaminated dust.
 ACUTE DISEASE: presenting as septicemia
with metastatic lesion.
 SUBACUTE DISEASE: presenting as TB like
pneumonia with cellulitis and lymphangitis.
 CHRONIC DISEASE: presenting as localized
cellulitis.
 The unusual antibiotic profile(gentamycin,
colistin resistance and amoxiclav susceptible)
in an oxidase+ve,gram−ve,motile,arginine+ve
rod is useful in confirming the diagnosis.
 Another important nonfermenter is genus
Bordetella. Three most common human
species are B.pertusis, B.parapertusis and B.
bronchiseptica.
 B.bronchiseptica is motile by peritrichous
flagella and grow readily on ordinary
media.It is an infrequent isolate in clinical
lab which rapidly convert Christensen’s urea
agar positive.
B.pertusis and parapertusis both cause
whooping cough, nonmotile and have special
growth requirement.They are grouped as
fastidious gram−ve rods.
NON-FERMENTERS

Weitere ähnliche Inhalte

Was ist angesagt? (20)

Oxidase Positive Non-fermenter GNB
Oxidase Positive Non-fermenter GNBOxidase Positive Non-fermenter GNB
Oxidase Positive Non-fermenter GNB
 
Enterococci
EnterococciEnterococci
Enterococci
 
Acinetobacter
AcinetobacterAcinetobacter
Acinetobacter
 
Streptococcus pneumoniae
Streptococcus pneumoniaeStreptococcus pneumoniae
Streptococcus pneumoniae
 
Staphylococcus
StaphylococcusStaphylococcus
Staphylococcus
 
Salmonella
SalmonellaSalmonella
Salmonella
 
Streptococcus pneumoniae
Streptococcus pneumoniaeStreptococcus pneumoniae
Streptococcus pneumoniae
 
15. shigella
15. shigella15. shigella
15. shigella
 
PNEUMOCOCCUS
PNEUMOCOCCUSPNEUMOCOCCUS
PNEUMOCOCCUS
 
Medical Microbiology Laboratory (Vibrio spp.)
Medical Microbiology Laboratory (Vibrio spp.)Medical Microbiology Laboratory (Vibrio spp.)
Medical Microbiology Laboratory (Vibrio spp.)
 
Haemophilus influenzae
Haemophilus influenzaeHaemophilus influenzae
Haemophilus influenzae
 
Medical Microbiology Laboratory (sample collection)
Medical Microbiology Laboratory (sample collection)Medical Microbiology Laboratory (sample collection)
Medical Microbiology Laboratory (sample collection)
 
Neisseria
NeisseriaNeisseria
Neisseria
 
Vibrio
VibrioVibrio
Vibrio
 
Hemolysis & blood agar abhijith
Hemolysis & blood agar abhijithHemolysis & blood agar abhijith
Hemolysis & blood agar abhijith
 
16. vibrio cholera
16. vibrio cholera16. vibrio cholera
16. vibrio cholera
 
13. e.coli
13. e.coli13. e.coli
13. e.coli
 
Medical Microbiology Laboratory (biochemical tests - iii)
Medical Microbiology Laboratory (biochemical tests - iii)Medical Microbiology Laboratory (biochemical tests - iii)
Medical Microbiology Laboratory (biochemical tests - iii)
 
Lab diagnosis of fungal infections, Dr Naveen Reddy
Lab diagnosis of fungal infections, Dr Naveen ReddyLab diagnosis of fungal infections, Dr Naveen Reddy
Lab diagnosis of fungal infections, Dr Naveen Reddy
 
Medical Microbiology Laboratory (streptococcus spp.)
Medical Microbiology Laboratory (streptococcus spp.)Medical Microbiology Laboratory (streptococcus spp.)
Medical Microbiology Laboratory (streptococcus spp.)
 

Andere mochten auch

Nonfermenters
NonfermentersNonfermenters
NonfermentersInam Khan
 
Culture-Abbas Morovvati
Culture-Abbas MorovvatiCulture-Abbas Morovvati
Culture-Abbas Morovvatiabbasmorovvati
 
Brandy Goudreau unknown project - negative
Brandy Goudreau unknown project - negativeBrandy Goudreau unknown project - negative
Brandy Goudreau unknown project - negativeBrandy Goudreau
 
carbohydrate metabolism
carbohydrate metabolismcarbohydrate metabolism
carbohydrate metabolismucisugiman
 
F 15 Lab 22 Carbohydrate metabolism
F 15 Lab 22 Carbohydrate metabolismF 15 Lab 22 Carbohydrate metabolism
F 15 Lab 22 Carbohydrate metabolismBharat Patel
 
Microbiology lab review
Microbiology lab reviewMicrobiology lab review
Microbiology lab reviewCameron Martin
 
5th lab 1st part biochemical tests (1)
5th lab 1st part biochemical tests (1)5th lab 1st part biochemical tests (1)
5th lab 1st part biochemical tests (1)Areej Abu Hanieh
 
Lab identification of enterobacteriacae
Lab identification of enterobacteriacaeLab identification of enterobacteriacae
Lab identification of enterobacteriacaeTripoli University
 
Anaesthesia machine 2014 spmc
Anaesthesia machine 2014 spmcAnaesthesia machine 2014 spmc
Anaesthesia machine 2014 spmcDeepak Choudhary
 
Types of culture media.pptx3.pdf 4
Types of culture media.pptx3.pdf 4Types of culture media.pptx3.pdf 4
Types of culture media.pptx3.pdf 4Univ. of Tripoli
 
Good Practice in Pharmaceutical Microbiology labratories
Good Practice in Pharmaceutical Microbiology labratoriesGood Practice in Pharmaceutical Microbiology labratories
Good Practice in Pharmaceutical Microbiology labratoriesEric Ittah
 

Andere mochten auch (20)

Pseudomonas fi
Pseudomonas fiPseudomonas fi
Pseudomonas fi
 
Nonfermenters
NonfermentersNonfermenters
Nonfermenters
 
Culture-Abbas Morovvati
Culture-Abbas MorovvatiCulture-Abbas Morovvati
Culture-Abbas Morovvati
 
Brandy Goudreau unknown project - negative
Brandy Goudreau unknown project - negativeBrandy Goudreau unknown project - negative
Brandy Goudreau unknown project - negative
 
TSI test
TSI  testTSI  test
TSI test
 
Carbohydrates
CarbohydratesCarbohydrates
Carbohydrates
 
carbohydrate metabolism
carbohydrate metabolismcarbohydrate metabolism
carbohydrate metabolism
 
Triple sugar iron_agar
Triple sugar iron_agarTriple sugar iron_agar
Triple sugar iron_agar
 
Tuba bashir
Tuba bashirTuba bashir
Tuba bashir
 
بكتريا عملي
بكتريا عملي بكتريا عملي
بكتريا عملي
 
F 15 Lab 22 Carbohydrate metabolism
F 15 Lab 22 Carbohydrate metabolismF 15 Lab 22 Carbohydrate metabolism
F 15 Lab 22 Carbohydrate metabolism
 
Microbiology lab review
Microbiology lab reviewMicrobiology lab review
Microbiology lab review
 
5th lab 1st part biochemical tests (1)
5th lab 1st part biochemical tests (1)5th lab 1st part biochemical tests (1)
5th lab 1st part biochemical tests (1)
 
Lab identification of enterobacteriacae
Lab identification of enterobacteriacaeLab identification of enterobacteriacae
Lab identification of enterobacteriacae
 
Anaesthesia machine 2014 spmc
Anaesthesia machine 2014 spmcAnaesthesia machine 2014 spmc
Anaesthesia machine 2014 spmc
 
Types of culture media.pptx3.pdf 4
Types of culture media.pptx3.pdf 4Types of culture media.pptx3.pdf 4
Types of culture media.pptx3.pdf 4
 
Microtaxonomy
MicrotaxonomyMicrotaxonomy
Microtaxonomy
 
Good Practice in Pharmaceutical Microbiology labratories
Good Practice in Pharmaceutical Microbiology labratoriesGood Practice in Pharmaceutical Microbiology labratories
Good Practice in Pharmaceutical Microbiology labratories
 
Media and biochemical tests
Media and biochemical testsMedia and biochemical tests
Media and biochemical tests
 
revision 2014
  revision  2014  revision  2014
revision 2014
 

Ähnlich wie NON-FERMENTERS

Nitrobacteriaceae & Pseudomonas
Nitrobacteriaceae & PseudomonasNitrobacteriaceae & Pseudomonas
Nitrobacteriaceae & PseudomonasAlia Najiha
 
Gram positive bacteria
Gram positive bacteria Gram positive bacteria
Gram positive bacteria Ramza Rasheed
 
Gram negative cocci
Gram  negative cocciGram  negative cocci
Gram negative cocciliji jesu
 
media and its types
media and its typesmedia and its types
media and its typesMicrobiology
 
5. Production of enzyme in biotechnolgy.pptx
5. Production of enzyme in biotechnolgy.pptx5. Production of enzyme in biotechnolgy.pptx
5. Production of enzyme in biotechnolgy.pptxHarshadaa bafna
 
culture media lecture 6.pptx
culture media lecture 6.pptxculture media lecture 6.pptx
culture media lecture 6.pptxOsmanAli92
 
SECONDARY METABOLITE PRODUCTION.pdf
SECONDARY METABOLITE PRODUCTION.pdfSECONDARY METABOLITE PRODUCTION.pdf
SECONDARY METABOLITE PRODUCTION.pdfManisha297529
 
Secondary metabolite production
Secondary metabolite productionSecondary metabolite production
Secondary metabolite productionAakilasahul3010
 
Secondary metabolites production
Secondary metabolites productionSecondary metabolites production
Secondary metabolites productionAli Safaa97
 
Preservatives, MOAs and Bacterial Resistance
Preservatives, MOAs and Bacterial ResistancePreservatives, MOAs and Bacterial Resistance
Preservatives, MOAs and Bacterial Resistancerahimbrave
 
Lactobacillales-Group-1-2-Presentation.pdf
Lactobacillales-Group-1-2-Presentation.pdfLactobacillales-Group-1-2-Presentation.pdf
Lactobacillales-Group-1-2-Presentation.pdfMcFerdieCBacton
 
5. Microbial transformation of recalcitrant chemicals.ppt
5. Microbial transformation of recalcitrant chemicals.ppt5. Microbial transformation of recalcitrant chemicals.ppt
5. Microbial transformation of recalcitrant chemicals.pptMimranjaved1
 
Isolation of Pure culture of Bacteria. Enzymes of Bacteria
Isolation of Pure culture of Bacteria. Enzymes of BacteriaIsolation of Pure culture of Bacteria. Enzymes of Bacteria
Isolation of Pure culture of Bacteria. Enzymes of BacteriaEneutron
 
Classification of Bacteria microbiology
Classification of Bacteria microbiologyClassification of Bacteria microbiology
Classification of Bacteria microbiologyVinay Dhiman
 
Preservatives, MOAs and Bacterial Resistance
Preservatives, MOAs and Bacterial ResistancePreservatives, MOAs and Bacterial Resistance
Preservatives, MOAs and Bacterial Resistancerahimbrave
 
CLASSIFICATION OF BACTERIA
CLASSIFICATION OF BACTERIACLASSIFICATION OF BACTERIA
CLASSIFICATION OF BACTERIAChaUhan Ar Shi
 

Ähnlich wie NON-FERMENTERS (20)

Nitrobacteriaceae & Pseudomonas
Nitrobacteriaceae & PseudomonasNitrobacteriaceae & Pseudomonas
Nitrobacteriaceae & Pseudomonas
 
Gram positive bacteria
Gram positive bacteria Gram positive bacteria
Gram positive bacteria
 
Gram negative cocci
Gram  negative cocciGram  negative cocci
Gram negative cocci
 
media and its types
media and its typesmedia and its types
media and its types
 
Clostridia
ClostridiaClostridia
Clostridia
 
5. Production of enzyme in biotechnolgy.pptx
5. Production of enzyme in biotechnolgy.pptx5. Production of enzyme in biotechnolgy.pptx
5. Production of enzyme in biotechnolgy.pptx
 
Campylobacter
CampylobacterCampylobacter
Campylobacter
 
culture media lecture 6.pptx
culture media lecture 6.pptxculture media lecture 6.pptx
culture media lecture 6.pptx
 
Gen
Gen Gen
Gen
 
SECONDARY METABOLITE PRODUCTION.pdf
SECONDARY METABOLITE PRODUCTION.pdfSECONDARY METABOLITE PRODUCTION.pdf
SECONDARY METABOLITE PRODUCTION.pdf
 
Secondary metabolite production
Secondary metabolite productionSecondary metabolite production
Secondary metabolite production
 
Secondary metabolites production
Secondary metabolites productionSecondary metabolites production
Secondary metabolites production
 
Preservatives, MOAs and Bacterial Resistance
Preservatives, MOAs and Bacterial ResistancePreservatives, MOAs and Bacterial Resistance
Preservatives, MOAs and Bacterial Resistance
 
Lactobacillales-Group-1-2-Presentation.pdf
Lactobacillales-Group-1-2-Presentation.pdfLactobacillales-Group-1-2-Presentation.pdf
Lactobacillales-Group-1-2-Presentation.pdf
 
Bacteria.ppt
Bacteria.pptBacteria.ppt
Bacteria.ppt
 
5. Microbial transformation of recalcitrant chemicals.ppt
5. Microbial transformation of recalcitrant chemicals.ppt5. Microbial transformation of recalcitrant chemicals.ppt
5. Microbial transformation of recalcitrant chemicals.ppt
 
Isolation of Pure culture of Bacteria. Enzymes of Bacteria
Isolation of Pure culture of Bacteria. Enzymes of BacteriaIsolation of Pure culture of Bacteria. Enzymes of Bacteria
Isolation of Pure culture of Bacteria. Enzymes of Bacteria
 
Classification of Bacteria microbiology
Classification of Bacteria microbiologyClassification of Bacteria microbiology
Classification of Bacteria microbiology
 
Preservatives, MOAs and Bacterial Resistance
Preservatives, MOAs and Bacterial ResistancePreservatives, MOAs and Bacterial Resistance
Preservatives, MOAs and Bacterial Resistance
 
CLASSIFICATION OF BACTERIA
CLASSIFICATION OF BACTERIACLASSIFICATION OF BACTERIA
CLASSIFICATION OF BACTERIA
 

NON-FERMENTERS

  • 1. PRESENTED BY—DR. ANINDYA DAS PGT, . DEPT. OF MICROBIOLOGY GMCH
  • 2.  Bacterial metabolism is a dynamic balance between anabolic reactions and catabolic reactions.  Catabolic reactions, in addition to providing smaller building blocks for subsequent biosynthetic processes also provide energy in the form of ATP.  Using this energy, bacterial cell wall,proteins nuclic acids,other structural and regulatory macromolecules are synthesised.
  • 3.  Bacteria that derive their energy from organic compounds are called chemoorganotrphs.  Most of the bacteria encountered in clinical medicine derive energy from the utilization of carbohydrates by one of several metabolic pathways.  Some free-living bacteria, such as the nitrogen- fixing groups or those capable of oxidizing sulfur or iron can derive energy from inorganic chemicals.They are called Chemolithotrophs.
  • 4.  Some bacteria, such as Moraxella, do not metabolize carbohydrates, but derive energy from degradation of other compounds,like amino acids, alcohols and organic acids.  Utilization of carbohydrates by bacteria and the condition under which this utilization occurs are key characteristics for broadly characterizing bacteria.  Many tests performed in Microbiology lab. for identification of bacteria are actually detection of the end products of bacterial metabolism.
  • 5.  Bacterial degradation of carbohydrate proceeds by three major pathways: Embden-Meyerhof- Parnas, Entner-Doudoroff and HMP pathway.  Glucose is converted to pyruvic acid in each of these three pathway by a different set of degradation steps.  Bacteria use one or more of these pathways for glucose metabolism depending on their enzymatic composition and the presence or lack of oxygen.
  • 6.  Utilization of glucose under anaerobic condition is termed fermentation.It occurs via glycolysis or EMP pathway with the intermediate product being pyruvic acid.  Pyruvate is then oxidized by giving up its H+ ion to Na-lactate to form lactic acid or to other organic salts to form mixed acids.  These acids are the end products of fermentation process accounting for the drop in Ph.
  • 7.  Bacteria that possess appropriate enzyme system can further degrade mixed acids into alcohols,carbon-di-oxide,or other compound.  Due to the absence of dehydrogenase enzyme some bacteria cannot ferment glucose.  They oxidatively metabolise glucose through Entner-Doudoroff pathway by forming 6- phosphogluconate before forming pyruvate and then transfer H+ into Krebs cycle.They are called Non-fermenters.
  • 8.  The acids produced in ED pathway and Kreb’ cycle are extremely weak compared with the mixed acids produced in fermentation.  As the end product of oxidative metabolism is water, no gas formation occurs here.  So the nonfermentative gram-negative bacilli are a group of aerobic,non-sporeforming bacilli that either do not use carbohydrate as a source of energy(eg. Moraxella) or degrade them through pathways other than fermentation.
  • 9. In Microbiology lab. nonfermenters are used to mean all aerobic gram- negative rods that show abundant growth within 24hrs on the surface of KIA or TSI media, but neither grow in nor acidify the butt of media
  • 10.  Achromobacter  Acidovorax  Acinetobacter  Agrobacterium  Alcaligenes  Bordetella  Brevundimonas  Burkholderia  Stenotrophomonas  Chryseobacterium  Chryseomonas  Comamonas  Flavimonas  Flavobacterium  Methylobacterium  Moraxella  Weeksella  Ochrobactrum  Oligella  Pseudomonas  Psychrobacter  Roseomonas  Shewanella  Sphingobacterium  Delftia  Ralstonia
  • 11.  They are predominantly opportunistic.  Pathogenecity of the organism is usually related to an altered or already debilitated host.  Nomenclature of these organisms changes rapidly due to defining of new genera with the use of molecular techniques.
  • 12.  They will grow on routine isolation media like blood agar, chocolate agar plate.  Growth on MacConkey agar is variable and this property is used for identification.  Optimum temperature of incubation ranges from 22-35ºC.  Most of them require an incubation time of at least 24 hrs, sometimes 48-72 hrs.
  • 13.  Most nonfermenters are oxidase +ve, but enterobacteriaceae are oxidase −ve.  Not all nonfermenters grow on MacConkey agar. Nonfermenters that grow on MacConkey agar are lactose negative.  Acid produced by nonfermenters are so weak that normal culture broths designed to detect acid produced by fermenters are not suitable for them.It can be easily identified in Hugh-Leifson OF media.
  • 14.  Some nonfermenters that are unable to utilize carbohydrates as energy sources are termed nonsaccharolytic or asaccholytic, eg- Moraxella, Alcaligenes etc.  Nonfermenters can rapidly develop resistance to antimicrobial agents used in treating infection.  A number of pigments are produced by nonfermenters, which are helpful in species identification,eg- carotenoids, violacein, phenazines, fluorescein, pyocyanine etc.
  • 15.  Organisms characterized as nonfermentative GNB are first differentiated based upon the combination of following three reactions- 1) Glucose oxidizer or glucose inactive(asaccharolytic). 2) MacConkey agar growth present or absent. 3) Oxidase+ve or oxidase−ve.  Once placed on one of the above groupings, the organisms are identified using a specific
  • 16. set of differential media(can be conventional or commercial systems like API 20NE, Vitek 1 and 2 system, Phoenix-Becton Dickinson etc.) or by species-specific rRNA based PCR assays.  Speciation of these organisms can be difficult.Reliability of commercial systems with some of these organisms is variable.
  • 17.  Pseudomonas is the most commonly isolated nonfermenting GNB.  Distribution is world wide and associated with water and moist environment.  Obligate aerobe,slender GNB,1.5-3x0.5µm.  Motile by polar monotrichus or multitrichus (tufts of) flagella.  Cytochrome oxidase positive.
  • 18.
  • 19.  Utilize carbohydrates oxidatively.  Grow on MacConkey agar producing non-lactose fermenting colonies.  Most commonly isolated species in the genus is Pseudomonas aeruginosa.  One of the leading causes of hospital acquired infection.  Not usually part of normal flora of healthy individuals.
  • 20.  Colonization occurs in the GI tract, throat, nasal mucosa, axilla and perinium.  Produces pigments like pyocianin(blue green) pyoverdin(yellow-green or yellow-brown, fluorescent), pyorubin(red), pyomelanin.  Cetrimide agar can be used to detect pyocyanin and pyoverdin production and selectively isolate the organism.
  • 21.  Colony morphology: BAP- spreading, flat, irregular edge, gray-green, with a metallic sheen, possibly mucoid, beta-hemolytic, and a grape like or corn taco-like odor.  MAC-clear, nonlactose fermenting colony.  Gram Stain morphology:thin gram −ve rod.  Pigment production: Pyocyanin, Pyoverdin, Pyomelanin, Pyorubin.
  • 22.
  • 23.
  • 24.  Glucose utilisation: glucose oxidizer(TSI- K/K, no gas, no H2S.)  Oxidase: Positive  Catalase:Positive  Lactose: Negative  Mannitol: Negative  Sucrose: Negative  42ºC growth: Positive  Arginine dihydrolase: Positive  Lysine decarboxylase: Negative
  • 25.  Ornithine decarboxylase: Negative  Gelatine hydrolysis: Variable  Nitrate: Positive  Citrate: Positive  Urease: Variable  Acetamide: Positive  Polymyxin-B: Sensitive  VIRULENCE FACTORS:  Pilli(attach to cell surface)  Lipopolysaccharide(endotoxin)
  • 26.  Alginate(capsular polysaccharide inhibit phagocytosis and form biofilms)  Exotoxin A: inhibit protein synthesis.  Other extracellular enzymes and toxins like proteases, elastase, neuraminidase, phospholypase-C, leucocidin, enterotoxin.  Pyocyanin: suppress other bacteria, disrupt respiraory cilliary activity.
  • 27.  Type of patients infected by Pseudomonas:  Leukocytopenic pt.  Immunosuppressed pt.  Extensive burn pt.  Cystic fibrosis and Diabetic pt.  Presence of indwelling foreign devices.  IV drug abuser.  Antibiotic therapy.  Immature immunologic system
  • 28.  Infected burn wounds.  Nosocomial infections like pneumonia.  Chronic pulmonary disease in Cystic fibrosis.  Septicemia.  Swimmer’s ear or otitis externa.  Folliculitis(swimming pool associated)  Corneal ulcer/keratitis,  Urinary tract infection,  Osteomylitis,  Ecthyma gangrenosum.
  • 29.
  • 30.  Pseudomonas aeruginosa is resistant to many commonly used antibiotics like Penicillin, Ampicillin, many 1st and 2nd generation Cephalosporins.  Sensitive to aminoglycosides,some 3rd generation cephalosporins, antipseudomonal penicillins(piperacillin,ticarcillin) and quinolonnes, carbapenems like imipenem, meropenem and aztreonam.  Aminoglycosides: affected by conc. of Ca, Mg ion of the medium.
  • 31.  The organisms are found in soil, water and hospital environment and on plants and foodstuffs.  Not part of normal human flora but can cause nosocomial infection.  LABORATORY IDENTIFICATION:  Colony morphology:BAP-smooth fairly large colonies, may have a pale yellow pigment.  MAC-growth (ambient air)
  • 32.  Gram morphology:thin GNB, sometimes with swollen ends, may be filamentous.  Motility: Negative.  Oxidase: Positive.  Glucose: Oxidizer.  Indole: Positive(may be weak,use Ehrlich’ method).  Nitrate reduction:Negative.  Esculine: Positive.  ONPG: Positive.  Polymyxin: Resistant.
  • 33.  Neonatal meningitis and sepsis. Highly pathogenic for premature infants. High mortality rate and chance of nursery epidemic.  Bacterimia associated with implanted catheters.  Other opportunistic infections.
  • 34.  MIC determination is recommended for clinically significant isolates.  Disc diffusion test is unreliable.  Susceptible to penicillin(usually), vancomycin (which is unusual for a gram negative organism), co-trimoxazole, fluoroquinolones, piperacillin/tazobactum.
  • 35.  Natural distribution is in water sources, detergents, disinfectants.Clusters of 9 closely related genomic species.  Isolated from pts. of CF and CGD.  LAB. IDENTIFICATION:  Colony morphology in BAP: smooth, slightly raised, may be mucoid, non-pigmented, strong earthy odor.  MAC: punctate and tenacious, may become dark pink red after 4-7 days.
  • 36.  Selective media for isolation is OFPBL media containing polymyxin B,bacitracin and lactose. Form yellow colony.  PC agar: polymyxin B, crystal violate, ticarcillin. Form pink colony due to lactose utilization.  Gram negative rod.  Oxidase: Positive.  Growth at 42ºC: Variable.  Glucose: Oxidizer.
  • 37.  Arginine dihydrolase: Negative.  Lysine decarboxylase: Positive.  Ornithine decarboxylase: Variable.  Polymyxin B: Resistant.  CLINICAL SIGNIFICANCE:  Organisms can be isolated from anesthetics, nebulizer solutions, IV fiuids and disinfectant like povidone-iodine, quaternary ammonium compounds and chlorhexidine.
  • 38.  Opportunistic pathogen primarily related to nosocomial infections and cystic fibrosis.  ANTIBIOTIC THERAPY:  Resistant to aminoglycosides.  Sensitive to co-trimoxazole(drug of choice).  CLSI: if susceptibility done with disc diffusion only report ceftazidime, meropenem, minocycline and co-trimoxazole.
  • 39.  3rd most commonly found nonfermenter in clinical specimen.  Ubiquitous in nature.Can be recovered from any clinical site.  Important nosocomial pathogen.  Not considered part of normal human flora. Can quickly colonize respiratory tract of hospitalized pts.  Have considerable genetic diversity.
  • 40.  BAP: colonies are pale yellow to lavender green(good growth at 24 hrs).  Gram negative rods.  Oxidase: Negative  Glucose: Oxidizer(weak).  Growth at 42ºC: Negative.  Maltose: Strong oxidizer.  Arginine dihydrolase: Negative.  Lysine decarboxylase: Positive.  Ornithine decarboxylase: Negative.
  • 41.  DNase: Positive.  Polymyxin B: Sensitive.  CLINICAL SIGNIFICANCE:  Usually cause pneumonia, wound infection, urinary tract infection, bacterimia in compromised host.  ANTIBIOTIC THERAPY:  Inherently resistant to commonly used anti- pseudomonal drugs.
  • 42.  Inherently susceptible to co-trimoxazole.  CLSI recommends broth dilution. Common antimicrobials include ticarcillin-clavulanate, levofloxacin and tetracycline.  If disc diffusion performed, only report minocycline, levofloxacin and co- trimoxazole.
  • 43.  After the genus Pseudomonas,it is the most frequently isolated nonfermenter.  Ubiquitous in soil, water and sewage.Can be part of normal skin flora.  Organism can survive on moist and dry surface. Strict aerobe.  In hospital environment isolated from ventilators, humidifiers and catheters.
  • 44.  Colony morphology on BAP is translucent to opaque, non-pigmented, convex.  On MAC colonies are colorless to slightly pink  Gram stain morphology is plump gram −ve coccobacilli, often appear to be diplococci, can be confused with Neiserria sp.  Oxidase: Negative.  Motility: Nonmotile.
  • 45.
  • 46.  Nitrate reduction: Negative.  Glucose: Oxidizer or asaccharolytic.  A.baumannii is saccharolytic glucose oxidizer.  Definitive identification: rapid production of acid from lactose.  A.lwoffi, A.johnsonii, A.radioresistens are asaccharolytic.  Penicillin: Resistant.  CLINICAL SIGNIFICANCE:  Generally considered non-pathogenic in healthy individuals.
  • 47.  Associated with opportunistic/nosocomial infection of respiratory tract, urinary tract, wound and blood.  ANTIBIOTIC SUSCEPTIBILITY:  Resistant to a variety of antibiotic like penicillin, ampicillin, cephalothin; variable susceptibility to 2nd and 3rd generation cephalosporin.  Combined rx with aminoglycoside+ticarcillin or piperacillin; sulbactum+cefoperazone;colistin for MDR sp.
  • 48.  Occur in water, soil, moist area of hospital, respirators, hemodialysis system, iv soln.  May be found on skin and in GI tract.  LAB. DIAGNOSIS:  Colony morphology of Alcaligenes fecalis is flat, thin, spreading and rough with an irregular edge, may have a fruity odor.  Gram −ve coccobacilli.
  • 49.  Oxidase: Positive.  Grow on MacConkey agar.  Glucose: weak oxidizer or asaccharolytic.  Motile by peritrichous flagella.  Reduce Nitrite(not Nitrate).  Achromobacter xylosoxidans is saccharolytic,  Glucose: weak oxidizer.  Xylose: strong oxidizer.  CLINICAL SIGNIFICANCE:  Alcaligenes fecalis is opportunistic pathogen
  • 50.  Isolated from blood, sputum, urine.  Achromobacter xylosoxidans causes nosocomial septicemia and pulmonary complications in Cystic Fibrosis pts. and intubated children.  ANTIBIOTIC THERAPY:  Susceptibility pattern varies.
  • 51.  Normal flora of skin and mucous membrane.  Non motile gram negative plump coccobacilli or diplobacilli.May resist decolorization.  On BAP tiny pinpoint colonies at 24 hrs., may pit the agar.  Most common sp. Moraxella catarrhalis is very similar to Neisseria sp.  Oxidase: Positive.
  • 52.  Catalase: Positive.  Glucose: non oxidizer(asaccharolytic)  Indole: negative.  Penicillin: highly susceptible.  CLINICAL SIGNIFICANCE:  Causes nosocomial and opportunistic infection like respiratory tract infection and conjunctivitis.  Production of β-lactamases has been reported mainly in M.catarrhalis.
  • 53.  Apart from these organisms some other medically important nonfermenters, though they are very rarely isolated from clinical specimens are Burkholderia mallei and pseudomallei.  B.mallei is an obligate parasite of animals like horses, mules and donkeys causing a RTI glanders.  In rare instances,it can be transmitted to humans through an abrasion of the skin.
  • 54.  It is gram-negative coccobacillus,only nonmotile sp. in the genus, oxidase −ve.  B.pseudomallei causes melioidosis, a glander like disease in animals and humans.  The organism has a specific ecological niche, existing in soil and stagnated water in parts of south-east asia like- Thailand,Vietnam,China,Taiwan and part of north Australia.
  • 55.  Infection is acquired by direct contact through break in the skin or by inhalation of contaminated dust.  ACUTE DISEASE: presenting as septicemia with metastatic lesion.  SUBACUTE DISEASE: presenting as TB like pneumonia with cellulitis and lymphangitis.  CHRONIC DISEASE: presenting as localized cellulitis.
  • 56.  The unusual antibiotic profile(gentamycin, colistin resistance and amoxiclav susceptible) in an oxidase+ve,gram−ve,motile,arginine+ve rod is useful in confirming the diagnosis.  Another important nonfermenter is genus Bordetella. Three most common human species are B.pertusis, B.parapertusis and B. bronchiseptica.  B.bronchiseptica is motile by peritrichous
  • 57. flagella and grow readily on ordinary media.It is an infrequent isolate in clinical lab which rapidly convert Christensen’s urea agar positive. B.pertusis and parapertusis both cause whooping cough, nonmotile and have special growth requirement.They are grouped as fastidious gram−ve rods.

Hinweis der Redaktion

  1. sp